GGrantIndex
← Leaderboards

Manisha Balwani

Icahn School Of Medicine At Mount Sinai

$4,522,531
Attributed
$6,218,276
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,856,043 · 8

By mechanism

U54$5,637,767 · 1
M01$2,033,548 · 3
U01$1,639,342 · 1
UH3$963,482 · 1
K23$905,904 · 1
UG3$676,000 · 1

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Others in their field

Top investigators on “Programs

Research focus

ProgramsSiteResearch PersonnelDiagnosisTrainingAffectChildRare DiseasesFundingClinical ResearchNatural HistoryPhenotypeCollaborationsDiagnosticPathogenesisGenomicsGenesMedical SchoolsEnrollmentGeneticChildhoodFacultyFamilyAcute

Grant awards (19)

Mount Sinai Center for Undiagnosed Diseases$816,633
U01 · FY2025 · NS
Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings$473,116
UH3 · FY2025 · TR
Mount Sinai Center for Undiagnosed Diseases$822,709
U01 · FY2024 · NS
Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings$490,366
UH3 · FY2024 · TR
Porphyrias Consortium$1,345,652
U54 · FY2023 · DK
Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings$338,000
UG3 · FY2023 · TR
Porphyrias Consortium$1,349,667
U54 · FY2022 · DK
Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings$338,000
UG3 · FY2022 · TR
Administrative Supplemental for Porphyria Rare Disease Clinical Research Consortium (RDCRC)$231,513
U54 · FY2022 · DK
Porphyrias Consortium$1,353,572
U54 · FY2021 · DK
Porphyrias Consortium$1,357,363
U54 · FY2020 · DK
Clinical and Molecular Studies of the Erythropoietic Protoporphyria Phenotype$192,240
K23 · FY2017 · DK · contact PI
Clinical and Molecular Studies of the Erythropoietic Protoporphyria Phenotype$178,416
K23 · FY2016 · DK · contact PI
Clinical and Molecular Studies of the Erythropoietic Protoporphyria Phenotype$178,416
K23 · FY2015 · DK · contact PI
Clinical and Molecular Studies of the Erythropoietic Protoporphyria Phenotype$178,416
K23 · FY2014 · DK · contact PI
Clinical and Molecular Studies of the Erythropoietic Protoporphyria Phenotype$178,416
K23 · FY2013 · DK · contact PI
NATURAL HISTORY AND TREATMENT OF GAUCHER DISEASE$331,291
M01 · FY2009 · RR · contact PI
NATURAL HISTORY AND TREATMENT OF GAUCHER DISEASE$809,296
M01 · FY2008 · RR · contact PI
NATURAL HISTORY AND TREATMENT OF GAUCHER DISEASE$892,961
M01 · FY2007 · RR · contact PI